Free Trial
NASDAQ:APVO

Aptevo Therapeutics (APVO) Stock Price, News & Analysis

Aptevo Therapeutics logo
$3.04 +0.10 (+3.22%)
As of 12:35 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Aptevo Therapeutics Stock (NASDAQ:APVO)

Key Stats

Today's Range
$2.92
$3.08
50-Day Range
$2.82
$14.80
52-Week Range
$2.81
$485.37
Volume
90,982 shs
Average Volume
604,350 shs
Market Capitalization
$2.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$219,040.00
Consensus Rating
Buy

Company Overview

Aptevo Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

APVO MarketRank™: 

Aptevo Therapeutics scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aptevo Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Aptevo Therapeutics has received no research coverage in the past 90 days.

  • Read more about Aptevo Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Aptevo Therapeutics are expected to grow in the coming year, from ($15.84) to ($14.49) per share.

  • Price to Book Value per Share Ratio

    Aptevo Therapeutics has a P/B Ratio of 0.05. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Aptevo Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    1.50% of the float of Aptevo Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Aptevo Therapeutics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aptevo Therapeutics has recently increased by 21.28%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Aptevo Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Aptevo Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.50% of the float of Aptevo Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Aptevo Therapeutics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aptevo Therapeutics has recently increased by 21.28%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Aptevo Therapeutics has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Aptevo Therapeutics this week, compared to 0 articles on an average week.
  • Search Interest

    14 people have searched for APVO on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Aptevo Therapeutics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aptevo Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.12% of the stock of Aptevo Therapeutics is held by insiders.

  • Percentage Held by Institutions

    Only 8.06% of the stock of Aptevo Therapeutics is held by institutions.

  • Read more about Aptevo Therapeutics' insider trading history.
Receive APVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

APVO Stock News Headlines

Banks aren’t ready for this altcoin—are you?
Want to see why we believe this could be the next evolution of financial infrastructure? The old financial system is showing cracks—and this altcoin might be ready to take its place
Aptevo Therapeutics Inc.
See More Headlines

APVO Stock Analysis - Frequently Asked Questions

Aptevo Therapeutics' stock was trading at $86.20 at the beginning of 2025. Since then, APVO shares have decreased by 96.5% and is now trading at $3.0050.
View the best growth stocks for 2025 here
.

Aptevo Therapeutics Inc. (NASDAQ:APVO) issued its quarterly earnings results on Thursday, May, 15th. The biotechnology company reported ($87.80) earnings per share for the quarter, missing the consensus estimate of ($84.20) by $3.60.

Aptevo Therapeutics shares reverse split on Wednesday, March 6th 2024.The 1-44 reverse split was announced on Wednesday, March 6th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 6th 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of APVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aptevo Therapeutics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Alibaba Group (BABA), Plug Power (PLUG) and Micron Technology (MU).

Company Calendar

Last Earnings
5/15/2025
Today
7/02/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:APVO
Employees
50
Year Founded
2016

Price Target and Rating

Average Stock Price Target
$219,040.00
High Stock Price Target
$219,040.00
Low Stock Price Target
$219,040.00
Potential Upside/Downside
+7,424,984.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.13 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.11 million
Price / Cash Flow
N/A
Book Value
$65.21 per share
Price / Book
0.05

Miscellaneous

Free Float
755,000
Market Cap
$2.24 million
Optionable
Not Optionable
Beta
5.59

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:APVO) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners